Neovascular (Wet) Age-related Macular Degeneration Clinical Trials
2 recruiting trials for Neovascular (Wet) Age-related Macular Degeneration. Eligibility criteria explained in plain English.
2
Total Trials
2
Recruiting Now
0
Phase 3 Trials
2
Sponsors
Recruiting Trials
RECRUITINGNCT06346600
A Long-term Follow-up Study to Evaluate SKG0106 in the Treatment of Patients With nAMD
This is a Prospective, Non-interventional, Multicenter, Long-term Follow-up Study to Evaluate SKG0106 in the Treatment of Patients with Neovascular (Wet) Age-related Macular...
Sponsor: Skyline TherapeuticsEnrolling: 8310 locations
RECRUITINGPhase 1 / Phase 2NCT05197270
4D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration
Phase 1/2 dose-escalation and randomized, controlled, masked expansion trial in adults with wet AMD undergoing active anti-VEGF treatment. Substudies will evaluate the safety and...
Sponsor: 4D Molecular TherapeuticsEnrolling: 21520 locations